Industry Growth Insights published a new data on “Antiemetics Market”. The research report is titled “Antiemetics Market research by Types (5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, Others), By Applications (Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Others), By Players/Companies GlaxoSmithKline, Merck, Sanofi Aventis, Bristol Myers Squibb, Eli Lilly, Pfizer, Astellas, Johnson & Johnson, Baxter”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Antiemetics Market Research Report
By Type
5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, Others
By Application
Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Others
By Companies
GlaxoSmithKline, Merck, Sanofi Aventis, Bristol Myers Squibb, Eli Lilly, Pfizer, Astellas, Johnson & Johnson, Baxter
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Antiemetics Market Report Segments:
The global Antiemetics market is segmented on the basis of:
Types
5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Merck
- Sanofi Aventis
- Bristol Myers Squibb
- Eli Lilly
- Pfizer
- Astellas
- Johnson & Johnson
- Baxter
Highlights of The Antiemetics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5-HT3 receptor antagonists
- Dopamine antagonists
- NK1 receptor antagonist
- Antihistamines (H1 histamine receptor antagonists)
- Cannabinoids
- Benzodiazepines
- Anticholinergics
- Steroids
- Others
- By Application:
- Chemotherapy
- Motion sickness
- Gastroenteritis
- General anesthetics
- Opioid analgesics
- Dizziness
- Pregnancy
- Food poisoning
- Emotional stress
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antiemetics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antiemetics are medications that help to reduce nausea and vomiting.
Some of the major players in the antiemetics market are GlaxoSmithKline, Merck, Sanofi Aventis, Bristol Myers Squibb, Eli Lilly, Pfizer, Astellas, Johnson & Johnson, Baxter.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Antiemetics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Antiemetics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Antiemetics Market - Supply Chain
4.5. Global Antiemetics Market Forecast
4.5.1. Antiemetics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Antiemetics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Antiemetics Market Absolute $ Opportunity
5. Global Antiemetics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Antiemetics Market Size and Volume Forecast by Type
5.3.1. 5-HT3 receptor antagonists
5.3.2. Dopamine antagonists
5.3.3. NK1 receptor antagonist
5.3.4. Antihistamines (H1 histamine receptor antagonists)
5.3.5. Cannabinoids
5.3.6. Benzodiazepines
5.3.7. Anticholinergics
5.3.8. Steroids
5.3.9. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Antiemetics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Antiemetics Market Size and Volume Forecast by Application
6.3.1. Chemotherapy
6.3.2. Motion sickness
6.3.3. Gastroenteritis
6.3.4. General anesthetics
6.3.5. Opioid analgesics
6.3.6. Dizziness
6.3.7. Pregnancy
6.3.8. Food poisoning
6.3.9. Emotional stress
6.3.10. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Antiemetics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Antiemetics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Antiemetics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Antiemetics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Antiemetics Demand Share Forecast, 2019-2029
9. North America Antiemetics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Antiemetics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Antiemetics Market Size and Volume Forecast by Application
9.4.1. Chemotherapy
9.4.2. Motion sickness
9.4.3. Gastroenteritis
9.4.4. General anesthetics
9.4.5. Opioid analgesics
9.4.6. Dizziness
9.4.7. Pregnancy
9.4.8. Food poisoning
9.4.9. Emotional stress
9.4.10. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Antiemetics Market Size and Volume Forecast by Type
9.7.1. 5-HT3 receptor antagonists
9.7.2. Dopamine antagonists
9.7.3. NK1 receptor antagonist
9.7.4. Antihistamines (H1 histamine receptor antagonists)
9.7.5. Cannabinoids
9.7.6. Benzodiazepines
9.7.7. Anticholinergics
9.7.8. Steroids
9.7.9. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Antiemetics Demand Share Forecast, 2019-2029
10. Latin America Antiemetics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Antiemetics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Antiemetics Market Size and Volume Forecast by Application
10.4.1. Chemotherapy
10.4.2. Motion sickness
10.4.3. Gastroenteritis
10.4.4. General anesthetics
10.4.5. Opioid analgesics
10.4.6. Dizziness
10.4.7. Pregnancy
10.4.8. Food poisoning
10.4.9. Emotional stress
10.4.10. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Antiemetics Market Size and Volume Forecast by Type
10.7.1. 5-HT3 receptor antagonists
10.7.2. Dopamine antagonists
10.7.3. NK1 receptor antagonist
10.7.4. Antihistamines (H1 histamine receptor antagonists)
10.7.5. Cannabinoids
10.7.6. Benzodiazepines
10.7.7. Anticholinergics
10.7.8. Steroids
10.7.9. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Antiemetics Demand Share Forecast, 2019-2029
11. Europe Antiemetics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Antiemetics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Antiemetics Market Size and Volume Forecast by Application
11.4.1. Chemotherapy
11.4.2. Motion sickness
11.4.3. Gastroenteritis
11.4.4. General anesthetics
11.4.5. Opioid analgesics
11.4.6. Dizziness
11.4.7. Pregnancy
11.4.8. Food poisoning
11.4.9. Emotional stress
11.4.10. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Antiemetics Market Size and Volume Forecast by Type
11.7.1. 5-HT3 receptor antagonists
11.7.2. Dopamine antagonists
11.7.3. NK1 receptor antagonist
11.7.4. Antihistamines (H1 histamine receptor antagonists)
11.7.5. Cannabinoids
11.7.6. Benzodiazepines
11.7.7. Anticholinergics
11.7.8. Steroids
11.7.9. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Antiemetics Demand Share, 2019-2029
12. Asia Pacific Antiemetics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Antiemetics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Antiemetics Market Size and Volume Forecast by Application
12.4.1. Chemotherapy
12.4.2. Motion sickness
12.4.3. Gastroenteritis
12.4.4. General anesthetics
12.4.5. Opioid analgesics
12.4.6. Dizziness
12.4.7. Pregnancy
12.4.8. Food poisoning
12.4.9. Emotional stress
12.4.10. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Antiemetics Market Size and Volume Forecast by Type
12.7.1. 5-HT3 receptor antagonists
12.7.2. Dopamine antagonists
12.7.3. NK1 receptor antagonist
12.7.4. Antihistamines (H1 histamine receptor antagonists)
12.7.5. Cannabinoids
12.7.6. Benzodiazepines
12.7.7. Anticholinergics
12.7.8. Steroids
12.7.9. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Antiemetics Demand Share, 2019-2029
13. Middle East & Africa Antiemetics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Antiemetics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Antiemetics Market Size and Volume Forecast by Application
13.4.1. Chemotherapy
13.4.2. Motion sickness
13.4.3. Gastroenteritis
13.4.4. General anesthetics
13.4.5. Opioid analgesics
13.4.6. Dizziness
13.4.7. Pregnancy
13.4.8. Food poisoning
13.4.9. Emotional stress
13.4.10. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Antiemetics Market Size and Volume Forecast by Type
13.7.1. 5-HT3 receptor antagonists
13.7.2. Dopamine antagonists
13.7.3. NK1 receptor antagonist
13.7.4. Antihistamines (H1 histamine receptor antagonists)
13.7.5. Cannabinoids
13.7.6. Benzodiazepines
13.7.7. Anticholinergics
13.7.8. Steroids
13.7.9. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Antiemetics Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Antiemetics Market: Market Share Analysis
14.2. Antiemetics Distributors and Customers
14.3. Antiemetics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GlaxoSmithKline
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi Aventis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bristol Myers Squibb
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eli Lilly
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Astellas
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Johnson & Johnson
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Baxter
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
&n